Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
Authors
Keywords
-
Journal
HYPERTENSION
Volume 63, Issue 4, Pages 698-705
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-01-21
DOI
10.1161/hypertensionaha.113.02002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation
- (2013) Kazuomi Kario HYPERTENSION RESEARCH
- Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
- (2012) Sarah Mangiafico et al. EUROPEAN HEART JOURNAL
- Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment
- (2012) Motohiro Shimizu et al. JOURNAL OF HYPERTENSION
- Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP
- (2012) Fima Macheret et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association
- (2011) Ji-Guang Wang et al. HYPERTENSION RESEARCH
- Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients?
- (2010) Kazuo Eguchi et al. BLOOD PRESSURE MONITORING
- Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study
- (2010) Yukiko Ishikawa et al. JOURNAL OF HYPERTENSION
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
- (2010) Luis Miguel Ruilope et al. LANCET
- Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
- (2009) Toshio Ogihara et al. HYPERTENSION RESEARCH
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study
- (2009) Jing Chen et al. LANCET
- Secular Trends in the Incidence of and Risk Factors for Ischemic Stroke and Its Subtypes in Japanese Population
- (2008) Michiaki Kubo et al. CIRCULATION
- Cardiovascular Disease and Risk Factors in Asia
- (2008) Hirotsugu Ueshima et al. CIRCULATION
- Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema
- (2007) R M Fryer et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started